Daniel Lynch - Net Worth and Insider Trading

Over the past 18 months, Daniel Lynch made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 175,899 shares made by Jeffrey W. Albers , a net sale of 11,217 shares made by Christopher K. Murray , and a net sale of 36,744 shares made by Michael Landsittel .

In summary, during the past 3 months, insiders sold 130,368 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 130,368 shares. During the past 18 months, 312,641 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 312,641 shares.

Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel Lynch made no insider transaction in bluebird bio Inc (BLUE). Other recent insider transactions involving bluebird bio Inc (BLUE) include a net sale of 32,050 shares made by Andrew Obenshain , a net sale of 12,339 shares made by Thomas J Klima , and a net sale of 10,267 shares made by Richard A Colvin .

In summary, during the past 3 months, insiders sold 17,438 shares of bluebird bio Inc (BLUE) in total and bought 0 shares, with a net sale of 17,438 shares. During the past 18 months, 68,689 shares of bluebird bio Inc (BLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 68,689 shares.

bluebird bio Inc (BLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel Lynch made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .

In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.

Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel Lynch made no insider transaction in SpringWorks Therapeutics Inc (SWTX). Other recent insider transactions involving SpringWorks Therapeutics Inc (SWTX) include a net sale of 42,039 shares made by Daniel Pichl , a net sale of 4,818 shares made by Julie Hambleton , and a net sale of 1,750,000 shares made by Jeffrey Lawrence Schwartz .

In summary, during the past 3 months, insiders sold 15,000 shares of SpringWorks Therapeutics Inc (SWTX) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 1,804,913 shares of SpringWorks Therapeutics Inc (SWTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,913 shares.

SpringWorks Therapeutics Inc (SWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel Lynch made no insider transaction in Sesen Bio Inc (SESN). Other recent insider transactions involving Sesen Bio Inc (SESN) include a net sale of 541,214 shares made by Thomas R Cannell , a net sale of 407,711 shares made by Monica Forbes , and a net sale of 259,049 shares made by Mark Sullivan .

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 71,436 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 71,436 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DNIB Unwind Inc (BINDQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DNIB Unwind Inc (BINDQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DNIB Unwind Inc (BINDQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Omega Alpha SPAC (OMEG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Omega Alpha SPAC (OMEG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Omega Alpha SPAC (OMEG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel Lynch made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 1,000 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 484,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Daniel Lynch made no insider transaction in 2seventy bio Inc (TSVT). Other recent insider transactions involving 2seventy bio Inc (TSVT) include a net sale of 103,830 shares made by Nick Leschly , a net sale of 53,904 shares made by Baird William D Iii , and a net sale of 41,403 shares made by Philip D Gregory .

In summary, during the past 3 months, insiders sold 0 shares of 2seventy bio Inc (TSVT) in total and bought 817,377 shares, with a net purchase of 817,377 shares. During the past 18 months, 207,878 shares of 2seventy bio Inc (TSVT) were sold and 2,021,033 shares were bought by its insiders, resulting in a net purchase of 1,813,155 shares.

2seventy bio Inc (TSVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of CARISMA Therapeutics Inc (CARM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARISMA Therapeutics Inc (CARM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CARISMA Therapeutics Inc (CARM)'s detailed insider trading history can be found in Insider Trading Tracker table.